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Dynamic MRIAim: This work aims to assess the role of dynamic and diffusion weighted magnetic reso-
nance imaging in diagnosis of hepatic focal lesions in cirrhotic patients.
Methods: A prospective study included 30 patients (42 focal lesions) who were evaluated
by dynamic contrast enhanced MRI and diffusion weighted imaging.
Results: Statistically significant difference was found between ADC values of malignant and
benign hepatic focal lesions. Statistically significant difference is noticed between different
types of benign hepatic focal lesions. No statistically significant difference could be
detected between different types of malignant hepatic focal lesions. Dynamic MRI yields
sensitivity 85%, specificity 80% and 83.3% accuracy. DW and ADC mapping revealed sensi-
tivity 90%, specificity 90% and accuracy of 90%.
Conclusion: The combination of Dynamic MRI and DW is sensitive for early detection of
malignant neoplastic hepatic lesions, and for differentiation between the benign and
malignant lesions.
 2016 The Egyptian Society of Radiology and Nuclear Medicine. Production and hosting by
Elsevier. This is an open access article under the CC BY-NC-ND license (http://creativecom-
mons.org/licenses/by-nc-nd/4.0/).1. Introduction
Liver cirrhosis is a major public health problem world-
wide. Common causes of cirrhosis include hepatitis C virus,
hepatitis B virus, alcohol consumption and non-alcoholic
steatohepatitis [1].
Imaging characterization of focal lesions in cirrhosis is
of the utmost importance for appropriate patient manage-
ment. The radiologist’s primary task is to maximize tumordetection, because missing the diagnosis of HCC may pre-
clude potentially curative therapies [2,3].
Magnetic resonance imaging (MRI) plays an increas-
ingly important role in the evaluation of patients with liver
disease because of its high contrast resolution, lack of ion-
izing radiation, and the possibility of performing functional
imaging sequences. DW MR imaging enables qualitative
and quantitative assessment of tissue diffusivity (apparent
diffusion coefficient) without the use of gadolinium che-
lates, particularly in patients with severe renal dysfunction
at risk for nephrogenic systemic fibrosis [4,5].
Diffusion of water molecules is the target of diffusion-
weighted imaging (DW-MRI), although water mobility in
biological systems is a complex process. Diffusion-
weighted measurement in the body is frequently
performed using Stejskal—Tanner echo-planar imaging
experiment. However, in living tissues there are
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diffusion processes and confound in vivo measurements. In
particular, the use of low b-values is sensitive to the micro-
capillary perfusion effects within the image voxel. Hence,
accurate estimation of the apparent diffusion coefficient
(ADC) of tissues in the body is dependent on the proper
choice of b-values, which, in turn, is influenced by the
baseline signal-to-noise and to the target tissue diffusion
properties. Body tissues also exhibit true multi-
exponential diffusion decay with increasing b-value that
is unrelated to false multi-exponential appearance due to
perfusion and/or noise. However, very high b-values
(e.g. >3000 s/mm2) are usually required to appreciate this
behavior [6].
Focal lesions in liver cirrhosis include hemangiomas,
focal nodular hyperplasia, adenomas, peribiliary cyst,
cholangiocarcinoma, metastasis, arterio-venous shunt,
focal confluent fibrosis and dysplastic nodules. Cirrhotic
patients are at higher risk of end stage liver disease, portal
hypertension, and hepatocellular carcinoma (HCC) [7,8].1.1. Aim of the work
The purpose of this study was to assess the role of
dynamic and diffusion weighted magnetic resonance
imaging in diagnosis of hepatic focal lesions in liver
cirrhosis.2. Patients and methods
2.1. Population
Between Jan 2015 and Jan 2016, 30 consecutive patients
referred for hepatic MRI because of hepatic focal lesions in
liver cirrhosis proved by ultrasonic examination. They
were prospectively enrolled. These 30 patients include 17
males and 13 females with age range between 30 and
70 year (mean age, 50 year). Inclusion criteria were
patients who presented with ultrasonic examination
revealing hepatic focal lesions in liver cirrhosis. Exclusion
criteria were the common contraindications to MRI (pace-
maker, metallic foreign bodies, and impaired renal func-
tion). This study was approved by the ethics committee
of our institution; an informed consent was obtained from
all patients after full explanation of the benefits and risks
of the procedure.3. Methods
Conventional MRI, post Gd-DTPA dynamic and diffusion
MR imaging studies were performed for all patients for
detection and characterization of hepatic focal lesions
were performed followed by diffusion weighted images
and ADC values. MR imaging was performed on high field
system (1.5 Tesla) magnet units (Toshiba Vintage) using a
phased array coil to cover the whole liver. Patients did
not undergo bowel preparation, but were instructed to fast
for at least 4 h before the examination. Intravenous injec-
tion of 20 mg of hyoscine-N butyl bromide (Buscopan)was injected 30 min before examination to reduce intesti-
nal peristalsis.
Pulse sequences and scanning planes are as follows:
A. Pre-contrast imaging included the following:
– T1 weighted image (T1WI) (TR/TE = 10 msec/
4.58 msec).
– T2 weighted images (T2WI) single shot free
breathing: (TR/TE 445 msec/26–28 msec).
– T2 SPAIR (Spectral Attenuated Inversion
Recovery) fat suppression sequence: (TR/TE =P
400 msec/80 msec).
– In phase and out phase gradient echo sequence
(Dual/FFE): TR/TE = 75–100 msec/4.6 msec for in
phase and TR/TE = 75–100 msec/2.3 msec for
out phase.B. Dynamic study: During dynamic MRI study, bolus
intravenous injection of 0.1 mmol/kg body weight
of Gd-DTPA at a rate of 2 ml/s flushed with 20 ml
of sterile 0.9% saline solution through the antecu-
bital vein was done. The injection of contrast media
and saline solution was performed automatically
using automatic injector. Dynamic imaging using
T1 THRIVE (High Resolution Isotropic Volume Exam-
ination) technique was performed in triphasic way
using dynamic study with continuous imaging to
obtain multiple arterial and portal phases after
administration of the contrast medium.
C. Diffusion study: Respiratory triggered fat sup-
pressed single-shot echoplanar DW imaging was
performed in the transverse plane with tri-
directional diffusion gradients by using b values
(500, 1000) sec/mm2. Parallel imaging with general-
ized auto-calibrating partially parallel acquisition
(GRAPPA) with an acceleration factor of two was
applied to improve image quality. The other param-
eters were as follows: repetition time (TR)
P1880 ms, echo time (TE) = 70 ms, scan time
3–4 min with a field of view as small as possible
with 52% rectangular field of view.3.1. Image analysis
The morphological features of each lesion were
recorded including size, shape, margin and signal charac-
teristics, pattern of enhancement in the dynamic imaging
as well as number and site of the detected focal lesions.
Then, provisional diagnosis was reported. Second, we
reviewed the diffusion images with ADC (range between
1.0–2.3  103 mm2/sec for benign lesions and 0.9–1.5 
103 mm2/sec for malignant lesions) values for final radio-
logical detection and characterization of focal lesions.
The mean ADC of each detected focal lesion is measured
by drawing a region of interest (ROI) over the lesion. The
ADC was measured twice and the two measurements were
averaged. To ensure that the same areas were measured,
regions of interest were copied and pasted from DW
images to ADC maps. The results were compared to labora-
tory and histopathology results in all patients.
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The data were analyzed with the SPSS 22 software
package. All quantitative variables were presented as
mean ± standard deviation and range. Qualitative data are
presented as number of frequency or percentages. Compar-
isons between the groups were done either with Chi
square test when both variables were qualitative or with
T independent test when one variable is quantitative and
other is qualitative. P value of less than 0.05 was consid-
ered statistically significant. Sensitivity and Specificity
and accuracy were calculated.Fig. 2. Box and whisker plot of ADC value among malignant and benign
hepatic focal lesions.
Fig. 3. Box and whisker plot of ADC value in benign hepatic focal lesions.4. Results
Thefinaldiagnosis of the42 focal lesionsdependingupon
histopathological results revealed 27malignant lesions and
15benign lesions. The benign lesionswere 2 adenomas (5%),
2 cysts having echogenic appearance on US (5%), 5 heman-
giomas (12%) and 6 regeneration nodules (14%). Among 27
malignant hepatic lesions, we had 15 HCC (35%), 10 metas-
tases (24%) and 2 cholangiocarcinomas (2%).
Among 15 focal lesions of HCC, 13 HCC lesions showed
low signals on T1WIs (Fig. 5) and one focal lesion had
isointense signals on T1WIs and another lesion elicits high
signal intensity (Fig. 4) due to its high fat content. The low
T1 signal intensity pattern is typically characteristic for
well differentiated HCC.
We noticed that 13 HCC lesions have high signals on
T2WIs (Fig. 5), and two cases exhibiting T2 intermediate
signal (Fig. 4). This intermediate T2 signal intensity is typ-
ically characteristic for well differentiated HCC lesions.
In dynamic MRI study, the majority of HCC lesions (14
lesions) displayed late arterial enhancement and gradual
contrast washout in the portal and delayed phases with
persistent delayed enhancing outer rim ‘‘capsule”. Fifteen
HCC lesions had restricted diffusion. This was one of the
MR characters to differentiate the malignant cirrhotic nod-
ules from other nodules which showed non-restricted
diffusion.
In two cases of intrahepatic cholangiocarcinoma (IHCs)
heterogeneous T2-weighted signal intensity and small
areas of strong hyperintensity are demonstrated. IHCsFig. 1. Box and whisker plot of ADC value in malignant hepatic focal
lesion.(Fig. 6) exhibit thick irregular peripheral enhancement
with progressive central enhancement on more delayed
images which is a pattern that is rarely seen in HCC.
On MRI diffusion study, two cysts show facilitated
diffusion.
Five hemangiomas (Fig. 7) demonstrate high signal
intensity on DW-MRI due to slow-flowing blood (b = 500
& 1000 s/mm2) while ADC map shows hyperintense
signals.
Among six regeneration nodules detected at four
patients (Fig. 8), three nodules show features suggestive
of high grade dysplastic nodules. Using of dynamic MR
imaging helps more in detection of these suspicious nod-
ules by noticing the enhancement pattern of these nodules
which was similar to that of hepatic parenchyma. While on
DW-MRI, the regenerating nodule signals were similar to
hepatic background.
The DW-MRI was conducted using high b value 500 s/
mm2 (Figs. 4 and 6) and 1000 s/mm2 (Figs. 5, 7 and 8) to
overcome the effect of capillary perfusion and water diffu-
sion in extracellular extravascular space. Furthermore, the
differences in the relative contrast ratio between malig-
nant and benign lesions were increased with a high b
value.
ADC values were obtained for all 42 focal hepatic
lesions detected at consensus reading.
Fig. 4. Sixty-five year old female patient presented with abdominal pain. Histopathological diagnosis of Hepato-cellular carcinoma. (A) Axial unenhanced
T1W image showed a lesion in the right hepatic lobe of iso to low signal intensity. (B) Axial T2W image showed a lesion of low signal intensity. (C) Axial
gadolinium-enhanced arterial-phase image showed intense enhancement of the lesion, typical of HCC. (D) Axial portal gadolinium-enhanced image showed
partial washout of the lesion. (E) Axial delayed gadolinium enhanced image showed washout of the lesion. (F) DWI (b500) showed the lesion to be of
increased signal intensity owing to restricted diffusion.
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1.605 ± 0.468  103 mm2/sec. ADC values of benign
lesions were ranging between 1.0  103 and
2.3  103 mm2/sec (Fig. 3) (Table 2).
The ADC values of the 27 malignant lesions were rang-
ing between 0.9 and 1.5  103 mm2/sec, with a mean
value of 1.12 ± 0.13  103 mm2/sec.
Statistically significant differences were found between
ADC values of benign and malignant hepatic focal lesions
with P value = <0.001 (Table 1) (Fig. 2).
The lowest mean ADC value was for breast metastasis,
while two HCCs were the highest mean ADC value.
There were no statistically significant differences in
ADC values among the different malignant lesions
(P < 0.358) (Table 3) (Fig. 1).
After revising imaging results and histopathological
examinations, dynamic MRI revealed 17 truly positive(benign and malignant) lesions, 3 false negative (radiolog-
ical pattern of regeneration nodule proved to be HCC and
one adenoma proved to be metastatic deposit), 8 true neg-
ative and 2 false positive (radiological pattern of HCC
proved to be regeneration nodules), with sensitivity 85%,
specificity 80% and 83.3% accuracy. DW and ADC mapping
revealed of 18 truly positive (benign and malignant)
lesions, 2 false negative radiological pattern of regenera-
tion nodule proved to be HCC, 9 true negative and 1 false
positive (radiological pattern of HCC proved to be regener-
ation nodules) with sensitivity 90%, specificity 90% and 90%
accuracy (Table 4).
5. Discussion
In this study, 13 HCC lesions were hypointense on
T1WIs, and one HCC focal lesion was isointense signals
Fig. 5. Sixty year old female patient presented with hematemesis. Suggested MR diagnosis is Hepato-cellular carcinoma. (A) Axial unenhanced T1W image
showed a large three hepatic focal lesions of low signal intensity. (B) Axial T2W images showed the lesions to be of increased signal intensity with more
brightness of their central part. (C) Axial gadolinium-enhanced arterial-phase image showed heterogeneously enhanced lesions with central areas of no
contrast uptake (necrosis), typical of HCC. (D) and (E) Axial portal gadolinium-enhanced and Axial delayed gadolinium-enhanced images showed washout
of the lesions with capsular enhancement. (F) DWI (b1000) showed the lesions to have increased signal intensity owing to restricted diffusion.
N.L. Debees et al. / The Egyptian Journal of Radiology and Nuclear Medicine 47 (2016) 1221–1230 1225on T1WIs and another HCC lesion showed high signal
intensity, and this high T1 signal was related to the fat con-
tent inside the lesions. The dual out-phase and in-phase
imaging techniques have been valuable in detection of
intracellular fat within these nodular lesions. On the other
hand, the low T1 signal intensity pattern is typically char-
acteristic for well differentiated HCC lesions. These find-
ings were also noted by Khatri et al. [29] who reported
that on T1-weighted images, HCCs are typically hypoin-
tense on T1WIs. On the other hand, Rieko et al. [8] found
that one-third of the cases of HCC were hyperintense on
T1WIs, and this high T1 signal intensity pattern has been
attributed to the presence of fat.In current study, we noticed that 13 HCC lesions were
hyperintense on T2WIs, and 2 cases elicited intermediate
signal. This intermediate T2 signal intensity pattern is typ-
ically characteristic for well differentiated HCC lesions.
Khatri et al. [29] reported similar MR features while Krin-
sky et al. [9] stated that 94% of their 47 HCC cases were
hyperintense on T2WIs. On the other hand, Van den Bos
et al. [10] reported that the signal intensity pattern of
HCC lesions may be variable on T2WIs, and HCC lesions
may be isointense or even hypointense relative to sur-
rounding liver on Fat Sat T2WIs.
Regarding our dynamic study, 14 HCC lesions displayed
the typical late arterial enhancement and gradual washout
Fig. 6. Fifty-eight year old female patient presented with abdominal pain and jaundice. Histopathological diagnosis of cholangiocarcinoma, (A) Axial T1W
image showed a mass lesion in the left hepatic lobe of low signal intensity. (B) Axial T2W image showed a lesion of heterogeneously increased signal
intensity. (C) Axial gadolinium-enhanced arterial-phase image showed diffuse enhancement of the lesion more prominent at the periphery. (D) and (E)
Axial portal gadolinium-enhanced and delayed images showed central fill in of the lesion. (F) DWI (b500) showed the lesion to be of increased signal
intensity owing to restricted diffusion.
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enhancing outer rim ‘‘capsule”. These findings were also
similar to the publications of Hanna et al. [11] and Willatt
et al. [12], and Khatri et al. [29], who stated that the arterial
enhancement (hypervascularity) and delayed hypointen-
sity are considered essential characteristic features for
HCC. Only one lesion of HCC may remain hyperintense rel-
ative to adjacent liver parenchyma on venous and delayed
phase images. However, about 10–20% of HCCs may be
hypovascular to the surrounding liver parenchyma on the
late arterial gadolinium-enhanced images, and this may
be related to lack of arterialization of the tumor and in
these cases diagnosis by imaging is difficult and biopsy is
essential, Khatri et al. [29].The study was conducted with b value (500 & 1000 s/
mm2) for DW-MRI to overcome the effect of capillary per-
fusion and water diffusion in extracellular extravascular
space, as high b value will result in the reduction in signal
from moving protons in the bile ducts, cysts, vessels and
fluid in the bowel. This will cause an increased contrast
between the lesion and liver. Furthermore, the differences
in the relative contrast ratio between malignant and
benign lesions were increased with a high b value. This
was similar to the b value used in studies carried out by
Demir et al. [13] and Hosny et al. [14].
All HCC lesions (15 lesions) included in this study had
restricted diffusion. This was one of the MR characters to
differentiate the malignant cirrhotic nodules from other
Fig. 7. Female patient aged forty-nine year with typical hemangioma, presented with abdominal pain. (A) Pre contrast CT showing hypodense lesion at
segment III of LT. Liver lobe (arrow head). Triphasic contrast enhanced CT showing (A) arterial phase showing peripheral enhancement of the lesion and (B)
portal phase showing more peripheral enhancement of the lesion, (D) delayed phase showing isodensity of the lesion with liver tissue (complete filling). (E)
Diffusion MR at b500, showing hyperintense signal of the lesion. (F) Corresponding ADC map showing hyperintense signal of the lesion, ADC value of the
lesion: 2.37  103 mm2/s. (G) Diffusion MR at b1000, showing hyperintense signal of the lesion. (H) Corresponding ADC map showing hyperintense signal
of the lesion, ADC value of the lesion: 2.11  103 mm2/s.
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are similar to those reported by Khatri et al. [29] who sta-
ted that, a mass in the cirrhotic liver with restricted diffu-
sion favors a solid lesion, and would be confirmatory for
HCC especially when the other MR features of HCC lesions
are present.
In this study, vascular invasion into the portal vein was
noticed in 2 cases of HCC lesions. On the other hand, Wil-
latt et al. [12] and Khatri et al. [29], both reported that the
incidence of malignant portal vein thrombosis in associa-
tion with HCC ranges from 5% to 44% in which it demon-
strates the same signal intensity and contrast
enhancement pattern as the primary tumor.
In the current study cysts and hemangiomas showed
facilitated diffusion whereas solid tumoral lesions showed
restricted diffusion. These data are similar to those present
in the literature. Taouli and Koh [15], stated that cellular
tissues, such as tumors, demonstrates restricted diffusion
(high signal intensity) on higher b value (500 s/mm2)
images and by contrast, cysts and hemangiomas show a
greater degree of signal attenuation on higher b value dif-
fusion images.
In this study, we have 5 hemangiomas in four cases, 4 of
them were relatively typical in appearance and one of
them appears with atypical appearance. However heman-
giomas rarely occur in end-stage cirrhosis, probably
because the cirrhosis obliterates existing hemangiomas.
When present in the cirrhotic liver, they are often atypical
and contain large areas of fibrosis. They do not washout
and instead remain isointense relative to the liver.
As regards hepatic adenomas were mildly hypointense
to moderately hyperintense on T1-weighted images and
mildly hyperintense on T2-weighted images, they show a
blush of homogeneous enhancement in the arterial phase
and become nearly iso-intense in later phases of dynamicgadolinium-enhanced imaging, adenomas characteristi-
cally show heterogeneous arterial phase enhancement that
fades to near iso-intensity after 1 min, this was found in
two cases, and the same results were obtained in the study
carried out by Ba-Ssalamah et al. [16].
As regards the Intra hepatic cholangiocarcinoma (IHC)
cases, IHC is more likely to appear as a discrete mass than
diffuse infiltrating HCC. The cases of IHCs typically demon-
strate heterogeneous T2-weighted signal intensity and
contain areas of strong hyperintensity. Contrast enhance-
ment characteristics also provide us the strongest differen-
tiation between the two entities. IHCs exhibit thick
irregular peripheral enhancement with progressive central
enhancement on more delayed images which is a pattern
that is rarely seen in HCC. The persistent enhancement
seen with IHC is generally a function of the fibrotic nature
of the tumor [17].
Unlike what we noticed in hemangiomas, the peripheral
enhancement of IHCs is not nodular or cloudlike and is not
similar to the blood pool enhancement. There was also
associated peripheral biliary ductal dilatation secondary
to mass effect from the IHCs and was associated with vol-
ume loss and capsular retraction which help furthermore
in diagnosis and in differentiation from HCC cases.
Although biliary ductal dilatation is not commonly associ-
ated with HCCs, if present, it may be mild and may actually
be intra-tumoral [18].
The diagnosis of hypervascular metastatic lesions was
more or less easier depending upon patient history reveal-
ing primary malignancy, so this raises the importance of
searching for a primary malignancy in cases we find multi-
ple hepatic nodular lesions even in cirrhotic patients.
At 6 regenerating nodule lesions in 4 patients, three
nodules show features suggestive of high grade dysplastic
nodules. Using of dynamic MR imaging helps more in
Fig. 8. Sixty year old male patient presented with right hypochondrial pain. Histopathological diagnosis of cirrhotic regenerating nodules. (A) Axial
unenhanced T1W image showed multiple lesions of isointense signal similar to the liver parenchyma. (B) Axial T2W image showed the lesions to be of low
signal intensity. (C) Axial gadolinium-enhanced arterial-phase image showed the lesions to be isointense. (D) and (E) Axial portal gadolinium-enhanced and
Axial delayed gadolinium-enhanced images showed the lesions to have isointense signal with no contrast washout. (F) DWI (b1000) showed the lesions to
be isointense.
Table 1
ADC values among 15 benign and 27 malignant hepatic focal lesions.
15 benign hepatic lesions 27 malignant hepatic lesions P value
ADC value Mean ± SD 1.605  103 ± 0.468  103 1.12  103 ± 0.130  103 <0.001
ADC value range 1  103–2.3  103 0.9  103–1.5  103
Table 2
ADC values among 15 benign hepatic focal lesions.






1.18  103 ± 0.092  103 2.25  103 ± 0.071  103 1.98  103 ± 0.192  103 1.217  103 ± 0.151  103 <0.001
ADC value range 1.12  103–1.25  103 2.2  103–2.3  103 1.8  103–2.3  103 1  103–1.4  103
Table 3
ADC values among 27 malignant hepatic focal lesions.
Metastasis 10 lesions HCC 15 lesions Cholangiocarcinoma 2 lesions P value
ADC value Mean ± SD 1.168  103 ± 0.163  103 1.095  103 ± 0.108  103 1.075  103 ± 0.035  103 0.358
ADC value range 0.9  103–1.5  103 0.9  103–1.3  103 1.05  103–1.1  103
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Table 4
Sensitivity and specificity of dynamic and DW MRI.
TR FN TN FP Sensitivity (%) Specificity (%) Accuracy (%)
Dynamic MRI 17 3 8 2 85 80 83.3
DW & ADC 18 2 9 1 90 90 90
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enhancement pattern of these nodules. This raises the
effectiveness and usefulness of dynamic MR imaging in
evaluation and characterization of hepatic focal lesions.
Researchers investigated the efficacy of DW imaging
based on quantitative analysis of apparent diffusion coeffi-
cient (ADC) values of liver lesions to differentiate between
benign and malignant lesions [19,20]. The results of most
of them were promising, as they demonstrated statistically
significant differences between higher mean ADC values of
benign lesions and lower mean ADC values of malignant
tumors [21–25]. Since the diffusion coefficient is related
to lesion cellularity and size of extracellular space, some
highly cellular benign lesions such as hepatocellular ade-
noma showed lower ADC values in the range of those of
malignant lesions [26].
Moreover, in a number of abscesses diffusion was
restricted because of cellular debris and exudates [27].
Conversely, some malignant lesions, mostly metastases,
demonstrated high ADC values [28].
In this study ADC values were obtained for all 42 focal
hepatic lesions detected at consensus reading. The mean
ADC value of the 15 benign lesions was
1.605 ± 0.468  103 mm2/sec. ADC values of benign
lesions were between 1.0  103 and 2.3  103 mm2/sec.
The highest mean ADC value was for simple cysts. Among
the benign lesions, adenoma had the lowest ADC value.
The ADC values of the 27 malignant lesions were
between 0.9 and 1.5  103 mm2/sec, with a mean value
of 1.12 ± 0.13  10 mm2/sec. Among the malignant lesions,
the lowest mean ADC value was for breast metastasis,
while some HCC focal lesion was the highest mean ADC
value. The difference between the mean ADC values of
benign and malignant lesions was statistically significant
(P < 0.001). There were no statistically significant differ-
ences in ADC values among the different the different
malignant lesions (P < 0.358), while it was significant
among the benign lesions (P < 0.001).
The study had some limitations:
We are aware of the major limitations of this study in
the form of the following:
(1) Relatively small number of patients, so future study
with large number of patients would be
recommended.
(2) There is the limitation of usage of one kind of con-
trast medium (Gd-DTPA) to identify the type of nod-
ules. Further research with more recent contrast
media for nodule characterization would be of great
value.
(3) Pathologic diagnosis was not available for some
patients. However these lesions showed specific
diagnostic imaging findings unchanged on serialimaging. Laboratory, clinical and radiological evalu-
ation of these lesions did not require histopatholog-
ical confirmation.
In conclusion, the combination of Dynamic MRI and DW
is sensitive for early detection of malignant neoplastic hep-
atic lesions, and for differentiation between the benign and
malignant lesions. This technique is complementary to
other imaging modalities and laboratory studies for full
assessment of the hepatocellular nodules in cirrhotic
livers.
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